Glucagon agonism, counterintuitively, helps by enhancing fat metabolism (lipolysis and fatty acid oxidation), reducing liver fat, and improving metabolic flexibility
Wesselman H, Ford CG, Leyva Y, et al
How it affects existing research For researchers currently working with semaglutide or tirzepatide , retatrutide's approval would expand the toolkit significantly
The pharmacies in the Facility Inspections Warning Letters section are FDA-registered 503B outsourcing facilities. They operate under stricter oversight, must follow current good manufacturing process (cGMP), and use ingredients sourced from FDA-registered suppliers
and the world have been using GLP-1s
This mechanistic difference suggests the potential for additive effects without direct pharmacological overlap